BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2016

Jul 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-07-14

Reporting Person: Davis George Eric (EVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-14	Common Stock	M	2656	$38.590	Acquired	73325	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-14	Stock Option (Right to buy) Common Stock	$38.59	M	2656	Disposed	2018-05-21	Common Stock (2656)	Direct

Footnotes

F1: Original option grant vests 6/48ths on November 22, 2008, and 1/48th on the 12th day of every month thereafter.

F2: Reflects the number of stock options that remain outstanding from this specific stock grant following the reported transaction.